Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning
RaySearch Laboratories AB (publ) announces that Oregon Health & Science University (OHSU) in the USA has placed an order for the treatment...
Month: October 2023
Essential Oil Company ĒLYSCE Launches Full Line of Aromatherapy Products Geared at Addressing Mental Health Concerns, Nurturing Happiness, and Promoting Overall Well-Being
ĒLYSCE, the newest essential oil company to hit the market, is thrilled to announce its full line of U.S.-made, high-quality...
Early Breast Cancer Detection With Auria Increases Through Strategic Partnerships
As breast cancer awareness month comes to a close, the fight for awareness and early-stage detection continues. The impact of Auria,...
Medline recognizes SHARE Cancer Support as its first Pink Glove Grant recipient
Medline today announced SHARE Cancer Support as the recipient of its first-ever Pink Glove Grant. SHARE will receive a $25,000 grant from the Medline...
Vesica Health Appoints Distinguished Urologic Oncologist Dr. William T. Lowrance to Chief Medical Officer
VESICA HEALTH, INC., a multi-omics, liquid biopsy company transforming the management of hematuria patients and improving the early detection of...
PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its groundbreaking...
Salignostics’ Salistick, the World’s First Saliva-Based Pregnancy Test, Recognized by TIME as One of the Best Inventions of 2023
Salignostics, an Israeli saliva research and product development start-up, is proud to announce its groundbreaking pregnancy test, Salistick, has been...
BRAINBox Solutions Announces Initial Series B Investments to Support U.S. Regulatory Clearance, Initial Commercialization of BRAINBox TBI Concussion Diagnostic/Prognostic Test
BRAINBox Solutions today announced initial investments into the company's Series B financing to support U.S. regulatory clearance and initial commercialization...
BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population
BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced...
The American Diabetes Association and Genentech Launch a Call to Action for Eye Exams to Prevent Diabetes-Related Vision Loss
The American Diabetes Association® (ADA), a sponsor of the 2023 Magic City Classic (MCC), and Genentech, anchor partner of the ADA's...
